Transforming the sensitivity, viability and profitability of lateral flow testing

Our revolutionary technology can make existing lateral flow tests 10 million times more sensitive

Our Techology

eAMP (enhanced Amplification) can be simply incorporated into existing manufacturing processes, and is easily customised for the chosen target illness. This means that:

beakerNew
Existing lateral flow tests become simpler to implement, more marketable and profitable
barchartNew
Vast numbers of illnesses can now be detected early and affordably using lateral flow tests
cashNew
Lateral flow could replace more complex and expensive tests like ELISA and PCR

Our Vision 

To transform healthcare with our new generation of lateral flow tests

Science

The research behind our discovery

Products

A new generation of lateral flow applications

Services

How we can support you

Our Team

The SwiftDx team